Osteosarcoma Ines Lohse, PhD “Drug Sensitivity Test for Treatment Stratification of Cancer Patients”

MIB Agents OsteoBites S2 Ep 11: Ines Lohse, PhD on “Drug Sensitivity Testing for the Treatment Stratification of Cancer Patients”
...
Guest Information:
Ines Lohse, PhD
Assistant Scientist
University of Miami
Center for Therapeutic Innovation
...
Dr. Lohse received her PhD from the University of Zurich in 2011. After postdoctoral fellowships at the Princess Margaret Cancer Center (Toronto) and the University of Michigan, Dr. Lohse moved to the University of Miami to focus on the preclinical and early clinical development of novel technology and therapeutic options for cancer patients. The Ex Vivo Drug Sensitivity Testing Platform has been successfully tested in a pilot cohort of patients, including sarcoma. It is currently in development to transition the platform to clinical routine.
...
Panelists
Mia Sandino, MIB Junior Board Member and OsteoWarrior
Charlotte Murdoff, MIB Junior Board Member and OsteoWarrior
Annika Vallejo, MIB Junior Board Member and OsteoWarrior Sibling
Ann Graham, OsteoWarrior & Executive Director of MIB Agents.
...
Coming up next week is Daniel Prince, MD, MPH Orthopedic Surgeon from Memorial Sloan Kettering Cancer Center on
“Regenerative Surgery for Bone Sarcomas”.
...
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our
community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
...
Register: https://bit.ly/MIBobites
Osteosarcoma Resources: www.MIBagents.org/contact
Dr. Lohse Contact: [email protected]
University of Miami Website: umiamihealth.org/sylvester-comprehensive-cancer-center/research/faculty/ines-lohse-phd